This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jan Fawcett, MD; Carl A. Aagesen, DO; Jeffrey M. Tilkin, MD; Marcella McGuire, RN; David C. Clark, PhD; Vincent D. Pisani, PhD; Donald Sellers, MD; Robert D. Gibbons, PhD
Department of Psychiatry Rush-Presbyterian—St Luke's Medical Center 1753 W Congress Pkwy Chicago, IL 60612

Arch Gen Psychiatry. 1989;46(3):290-291.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We are pleased that Dr Flemenbaum, an early advocate of lithium carbonate trials for alcoholic patients with primary subsyndromal affective disorder, brought his article¹ and hypotheses to our attention, and we apologize for overlooking it in our initial reports. In his 1974 report, he proposed symptomatic criteria that might distinguish between primary alcoholism and alcoholism secondary to subsyndromal affective disorder and, therefore, between alcoholics who might and might not benefit from lithium carbonate therapy.

In the course of the 1985 American Psychiatric Association presentation, Dr Flemenbaum mentioned that one of us (J.F.) reported preliminary results of our study on lithium carbonate therapy for alcoholism.^2,3 The numbers Dr Flemenbaum attributes to us are not the same numbers we presented, and this error accounts for our different interpretations. Our research staff interviewed patient subjects and significant others between seven and 21 days following admission to an inpatient alcoholism rehabilitation . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?